Related Experiment Video
Updated: Jul 30, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Extracorporeal life support for children with meningococcal septicaemia
D K Luyt1, J Pridgeon, J Brown
1Heartlink ECMO Centre, Glenfield Hospital, Leicester, United Kingdom.
Insights
Extracorporeal membrane oxygenation (ECMO) shows promise for children with severe meningococcal sepsis and ARDS. However, outcomes for those with refractory shock and MODS remain poor despite ECMO treatment.
Area of Science:
- Pediatric Critical Care Medicine
- Infectious Diseases
- Cardiopulmonary Support
Background:
- Meningococcal sepsis is a life-threatening condition in children.
- Severe cases often lead to multi-organ dysfunction syndrome (MODS) and respiratory failure.
- Extracorporeal membrane oxygenation (ECMO) is a potential life-support intervention.
Purpose of the Study:
- To evaluate the short-term outcomes of pediatric patients with meningococcal sepsis treated with ECMO.
- To compare the effectiveness of different ECMO configurations (veno-venous vs. veno-arterial) in specific clinical scenarios.
Main Methods:
- Retrospective analysis of case notes from a single ECMO center.
- Inclusion of 11 children treated for meningococcal sepsis with ECMO.
- Categorization of patients based on presenting condition: ARDS or refractory shock with MODS.
Main Results:
- Children with severe ARDS had a high survival rate (5/5) with veno-venous (VV-) ECMO.
- Children with refractory shock and MODS had a low survival rate (1/6) despite veno-arterial (VA-) ECMO.
- All ECMO patients had a high predicted risk of death (GMSPS ≥ 12).
Conclusions:
- VV-ECMO is a potentially successful treatment for pediatric meningococcal sepsis with severe ARDS.
- VA-ECMO offers limited benefit for children with refractory shock and MODS due to meningococcal sepsis.
- Further research is needed to determine ECMO's overall advantage over conventional therapies.
Objective:
To describe the short-term outcome of children with meningococcal sepsis treated with extracorporeal membrane oxygenation (ECMO) in a single centre.
Design:
Retrospective analysis of case notes.
Setting:
The Heartlink ECMO Centre, Glenfield Hospital, Leicester.
Patients:
Eleven children (8 boys) out of a total caseload of 800 patients were treated for meningococcal sepsis with ECMO.
Interventions:
Extracorporeal membrane oxygenation.
Results:
All children with meningococcal sepsis treated with ECMO had a Glasgow Meningococcal Septicaemia Prognostic Score (GMSPS) > or = 12 (positive predictive risk of death of approximately 90%). Five children had adult respiratory distress syndrome (ARDS) and six had refractory shock with multi-organ dysfunction syndrome (MODS) at presentation for ECMO. All five children in the ARDS group survived, four of five receiving veno-venous (VV-) ECMO therapy. In contrast, only one of six children with refractory shock with MODS survived, all of whom required veno-arterial (VA-) ECMO therapy.
Conclusions:
Most children with meningococcal sepsis and severe ARDS can be successfully treated with VV-ECMO. In contrast, children with refractory shock and MODS die despite treatment with VA-ECMO. This report does not resolve whether ECMO therapy offers any advantage over conventional therapy in treating severe meningococcal sepsis.
More Related Videos
Related Concept Videos
Rocky Mountain Spotted Fever
Viral Meningitis
Bacterial Meningitis I: Introduction

